Literature DB >> 27457822

Unilateral nevoid acanthosis nigricans treated with CO2 laser.

Manuel António Campos1, Paulo Varela1, Armando Baptista1, Eduarda Osório Ferreira2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27457822      PMCID: PMC4964191          DOI: 10.1136/bcr-2016-216073

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


× No keyword cloud information.

Description

Acanthosis nigricans (AN) can be classified into eight variants, including the benign, obesity associated, syndromic, malignant, acral, unilateral, medication induced and mixed type.1 Unilateral nevoid AN (UNAN) is an extremely rare form of AN and may be localised as a solitary lesion or along the Blaschko's lines.2 It is not associated with syndromes, endocrinopathies, drugs or malignancies. Various treatments have been described, including retinoids, calcipotriol, fish oil, ammonium lactate cream, cryotherapy, dermabrasion, excision (if small lesion) and long-pulse alexandrite laser treatment, with variable results.3 We report the case of a 9-year-old girl presenting to our department with asymptomatic, velvety, thickened orange-brown plaques distributed in an arciform pattern along the right scapular region (figure 1A). Her skin lesions appeared at the age of 5 years without any erythematous component, and these slowly increased in size over a 5-year period. Her familial and medical histories were unremarkable. No triggering factor was reported. Histological examination revealed hyperkeratosis, papillomatosis and moderate acanthosis of the epidermis. Based on the clinical and histopathological features, a diagnosis of unilateral nevoid AN was made.
Figure 1

(A) Polycyclic velvety thickened orange-brown plaques distributed in an arciform pattern along the right scapular region. (B) Cicatricial plaques 14 months after the last CO2 laser treatment.

(A) Polycyclic velvety thickened orange-brown plaques distributed in an arciform pattern along the right scapular region. (B) Cicatricial plaques 14 months after the last CO2 laser treatment. We performed two cycles of pulsed CO2 laser (2.6 J/cm2), with a 2-month interval between sessions. After 14 months of follow-up, she presents with cicatricial plaques that have gradually disappeared and the final cosmetic result is considered as very satisfactory by the parents (figure 1B). To the best of our knowledge, this is the only case of UNAN successfully treated with CO2 laser. Since no randomised controlled trials exist, we believe this treatment modality should be considered as an option. Unilateral nevoid acanthosis nigricans is an extremely rare form of acanthosis nigricans that is not associated with syndromes, endocrinopathies, drugs or malignancies. Various treatments have been described with variable results. Although not described in the literature, pulsed CO2 laser should be considered as a treatment option.
  3 in total

1.  Unilateral nevoid acanthosis nigricans.

Authors:  A S Krishnaram
Journal:  Int J Dermatol       Date:  1991-06       Impact factor: 2.736

Review 2.  The acanthosis nigricans form of epidermal nevus.

Authors:  Sibel Ersoy-Evans; Sedef Sahin; Anthony J Mancini; Amy S Paller; Joan Guitart
Journal:  J Am Acad Dermatol       Date:  2006-10       Impact factor: 11.527

3.  Acanthosis nigricans.

Authors:  R A Schwartz
Journal:  J Am Acad Dermatol       Date:  1994-07       Impact factor: 11.527

  3 in total
  3 in total

1.  Comparative study using fractional carbon dioxide laser versus glycolic acid peel in treatment of pseudo-acanthosis nigricans.

Authors:  N S Zaki; R F Hilal; R M Essam
Journal:  Lasers Med Sci       Date:  2018-04-30       Impact factor: 3.161

2.  Periumbilical Acanthosis Nigricans along the Surgical Site of Umbilical Hernia Operation.

Authors:  Tubanur Çetinarslan; Kamer Gündüz; Peyker Temiz
Journal:  Indian J Dermatol       Date:  2020 Jan-Feb       Impact factor: 1.494

Review 3.  Genital and Inverse/Intertriginous Psoriasis: An Updated Review of Therapies and Recommendations for Practical Management.

Authors:  Julie J Hong; Megan L Mosca; Edward K Hadeler; Nicholas D Brownstone; Tina Bhutani; Wilson J Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.